Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharmaceuticals crawled date : 2022 - 10 - 25 save search
Supernus Pharmaceuticals to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 8, 2022
Published: 2022-10-25 (Crawled : 21:00) - globenewswire.com
SUPN | $29.97 -0.07% 130K
|
Health Technology
|
| O: 0.73%
H: 1.2%
C: 0.14%
pharmaceuticals conference financial results
Corvus Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Ciforadenant as Potential First Line Treatment for Patients with Renal Cell Cancer
Published: 2022-10-25 (Crawled : 20:00) - globenewswire.com
CRVS | $1.47 68K
|
Health Technology
|
| O: 3.56%
H: 2.67%
C: -3.51%
treatment pharmaceuticals renal trial potential cancer phase 2b
Rhythm Pharmaceuticals to Present Full Data from Phase 2 Clinical Trial Evaluating Setmelanotide in Hypothalamic Obesity at ObesityWeek® 2022
Published: 2022-10-25 (Crawled : 15:00) - globenewswire.com
RYTM | $39.34 -1.87% 230K
|
Health Technology
|
| O: 1.03%
H: 7.31%
C: 3.31%
obesityweek obesity pharmaceuticals trial setmelanotide phase 2
Timber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive Ichthyosis
Published: 2022-10-25 (Crawled : 13:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 2.67%
H: 1.3%
C: -3.51%
tmb-001 pharmaceuticals designation positive
Marinus Pharmaceuticals to Provide Business Update and Report Third Quarter 2022 Financial Results on November 8, 2022
Published: 2022-10-25 (Crawled : 12:20) - biospace.com/
MRNS | $1.19 -8.46% 16M
|
Health Technology
|
| O: -0.21%
H: 5.12%
C: 3.41%
pharmaceuticals report financial update results
Paratek Pharmaceuticals to Report Third-Quarter 2022 Financial Results on Nov. 3
Published: 2022-10-25 (Crawled : 12:00) - globenewswire.com
PRTK | $2.23 0.0% 4.8M
|
Health Technology
|
| O: 0.0%
H: 8.43%
C: 6.93%
pharmaceuticals report financial results
Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022
Published: 2022-10-25 (Crawled : 12:00) - globenewswire.com
CPRX | $15.6 1.37% 370K
|
Health Technology
|
| O: 0.7%
H: 4.02%
C: 2.85%
pharmaceuticals report financial results
Milestone Pharmaceuticals Announces Late-Breaking Presentation of Data from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray
Published: 2022-10-25 (Crawled : 12:00) - biospace.com/
MIST | $1.74 -0.86% 99K
|
Health Technology
|
| O: 0.79%
H: 14.87%
C: 7.44%
etripamil pharmaceuticals spray rapid trial presentation milestone
Tonix Pharmaceuticals Announces Pricing of $15 Million Private Placement of Convertible Redeemable Preferred Stock
Published: 2022-10-25 (Crawled : 11:00) - globenewswire.com
TNXP | $0.1424 -2.4% 4.9M
|
Health Technology
|
| O: 1.36%
H: 4.0%
C: -0.2%
pharmaceuticals
Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC
Published: 2022-10-25 (Crawled : 11:00) - globenewswire.com
FUSN | $21.25 -0.14% 370K
|
Health Technology
|
| O: -0.42%
H: 3.77%
C: -4.26%
DFFN 4 | $6.6 11.68% -34.32% 350K
|
Health Technology
|
| O: 2.15%
H: 5.46%
C: 3.99%
pharmaceuticals review
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
WISA 4 | $5.33 204.57% 190M
|
Electronic Technology
TPET | $0.5189 124.54% 38M
|
n/a
SXTC | $1.78 52.14% 33M
|
Health Technology
JAGX | $0.1771 49.07% 540M
|
Health Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
FNCH | $2.98 32.74% 400K
|
Professional, Scientific, and T...
PALI | $5.51 32.45% 28M
|
Manufacturing
VERO | $0.804 31.8% 110K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.